Abstract
Chemotherapy agents such as cyclophosphamide (Cy) and doxorubicin (D) act through diverse mechanisms of action. We have previously shown that both agents result in apoptotic death of human primordial follicles. Sphingosine-1-Phosphate (S1P) is a ceramide-induced death pathway inhibitor. Our aim was to elucidate whether S1P can prevent Cy or D-induced apoptotic follicle death in human ovarian xenografts.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
